SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-05-001059
Filing Date
2005-11-18
Accepted
2005-11-18 08:04:12
Documents
12
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a13901e10vk.htm 10-K 2397921
2 EXHIBIT 10.278 a13901exv10w278.txt EX-10.278 30571
3 EXHIBIT 10.279 a13901exv10w279.txt EX-10.279 23940
4 EXHIBIT 10.280 a13901exv10w280.txt EX-10.280 4198
5 EXHIBIT 10.281 a13901exv10w281.txt EX-10.281 13117
6 EXHIBIT 10.282 a13901exv10w282.txt EX-10.282 16867
7 EXHIBIT 23.1 a13901exv23w1.htm EX-23.1 1863
8 EXHIBIT 31.1 a13901exv31w1.htm EX-31.1 6349
9 EXHIBIT 31.2 a13901exv31w2.htm EX-31.2 6340
10 EXHIBIT 32.1 a13901exv32w1.htm EX-32.1 3961
11 EXHIBIT 32.2 a13901exv32w2.htm EX-32.2 3953
12 GRAPHIC a13901a1390101.gif GRAPHIC 6594
  Complete submission text file 0000892569-05-001059.txt   2519747
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 051213932
SIC: 2834 Pharmaceutical Preparations